Q&A: Why regulators may toss cold water on buzz over psychedelics
Interest in psychedelics is surging, fueled by growing research suggesting they have a place in treatment of conditions like depression and post-traumatic stress disorder. But regulatory challenges loom.
Jan 25, 2024
0
1